Dark Chocolate May Slow Ageing and Improve Health Markers
Scientists Say Experimental Drug May Solve Common Issues Patients Have on Metabolic drugs
Betel Leaves Show Potential in Alzheimer’s Research
New Research Suggests Diet and Exercise Could Reduce Chemo Side Effects
Long COVID Research Gets a Major Funding Boost
LSU Researcher Invents New Ball Game Device to Transform Public Health Testing
The Coffee Timing Trick That Doubles Its Health Benefits
Medicine Is Entering Its Sci-Fi Era — And It’s Happening Faster Than Anyone Expected
The Shot That Could Rewrite Women’s Health
July 30,2024
Potential Breakthrough in Obesity Drugs: Targeting Brain Neurons to Avoid Nausea
Nausea is a common side effect of obesity and Type 2 diabetes medications like Ozempic and Wegovy, often leading some users to discontinue their use. However, scientists at the Monell Chemical Senses Center in Philadelphia have discovered a collection of neurons in the brains of mice that may promote weight loss without causing nausea.
The researchers suggest that obesity drug developers should focus on the nucleus tractus solitarius, a crucial brainstem structure that processes taste information. Amber L. Alhadeff, the senior study author and assistant member at Monell, stated, "Developing experimental obesity drugs that selectively activate this population may promote weight loss while avoiding aversive side effects."
.jpg)
Copyright © 2025 Dotcom Africa. All Rights Reserved. Advertising Terms | Terms of Use | Contact | Advertise with us | About Us